FDA NDC Directory · JSON-LD · Markdown

AMJEVITA

NDC 84612-399 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameadalimumab-atto
Labeler / ManufacturerNuvaila Limited
Marketing categoryBiologic License Application · App BLA761024
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsADALIMUMAB (20 mg/.2mL)
Marketing started20250101
Package count1

External sources

Source: openFDA. Public-domain (CC0).